Accelerated stem cell labeling with ferucarbotran and protamine

European Radiology

Volumn 20, Issue 3, 2010, Pages 640-648

  Golovko, Daniel M ^a   Henning, Tobias ^a   Bauer, Jan S ^a   Settles, Marcus ^b   Frenzel, Thomas ^c   Mayerhofer, Artur ^d   Rummeny, Ernst J ^b   Daldrup Link, Heike E ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c BAYER PHARMA AG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell labeling; Contrast agent; Ferucarbotran; Mesenchymal stem cell; Protamine

Indexed keywords

FERUCARBOTRAN; IRON OXIDE; PROTAMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; MAGNETITE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; CELL CULTURE; CELL LABELING; CELL VIABILITY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE QUALITY; INCUBATION TIME; LYSOSOME; MALE; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPECTROSCOPY; STEM CELL; CYTOLOGY; MESENCHYMAL STEM CELL; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STAINING;

CONTRAST MEDIA; FERROSOFERRIC OXIDE; HUMANS; MALE; MESENCHYMAL STEM CELLS; PROTAMINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; YOUNG ADULT;

EID: 77952303687     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1585-1     Document Type: Article

References (42)

1. Soria B, Roche E, Berna G, Leon- Quinto T, Reig JA, Martin F (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49:157-162
2. Freed CR, Greene PE, Breeze RE et al (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719
3. Yoon YS, Lee N, Scadova H (2005) Myocardial regeneration with bonemarrow- derived stem cells. Biol Cell 97:253-263
4. Gregory CA, Prockop DJ, Spees JL (2005) Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp Cell Res 306:330-335
5. Chen SL, Fang WW, Ye F et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95 (Pubitemid 38813459)
6. Jain M, Pfister O, Hajjar RJ, Liao R (2005) Mesenchymal stem cells in the infarcted heart. Coron Artery Dis 16:93-97
7. Frangioni JV, Hajjar RJ (2004) In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110:3378-3383
8. Bulte JW, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499
9. Daldrup-Link HE, Rudelius M, Piontek G et al (2005) Migration of iron oxidelabeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 234:197-205
10. Arbab AS, Yocum GT, Wilson LB et al (2004) Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 3:24-32
11. Franklin RJ, Blaschuk KL, Bearchell MC et al (1999) Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. Neuroreport 10:3961-3965
12. Josephson L, Tung CH, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186-191
13. Bulte JW, Douglas T, Witwer B et al (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141-1147
14. Sorgi FL, Bhattacharya S, Huang L (1997) Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 4:961-968 (Pubitemid 27437722)
15. Lochmann D, Jauk E, Zimmer A (2004) Drug delivery of oligonucleotides by peptides. Eur J Pharm Biopharm 58:237-251
16. Dinauer N, Lochmann D, Demirhan I et al (2004) Intracellular tracking of protamine/ antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation. J Control Release 96:497-507
17. Arbab AS, Yocum GT, Kalish H et al (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217-1223
18. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14:1851-1858
19. Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266-1276
20. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40:715-724
21. In den Kleef JJ, Cuppen JJ (1987) RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med 5:513-524
22. Wang ML, Nesti LJ, Tuli R et al (2002) Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20:1175-1184
23. Graziani-Bowering GM, Graham JM, Filion LG (1997) A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes. J Immunol Methods 207:157-168. doi: S0022-1759(97)00114-122 [pii]
24. Albrecht M, Ramsch R, Kohn FM, Schwarzer JU, Mayerhofer A (2006) Isolation and cultivation of human testicular peritubular cells: a new model for the investigation of fibrotic processes in the human testis and male infertility. J Clin Endocrinol Metab 91:1956-1960
25. Muller RN, Gillis P, Moiny F, Roch A (1991) Transverse relaxivity of particulate MRI contrast media: from theories to experiments. Magn Reson Med 22:178-182 discussion 195-1176
26. Balhorn R (2007) The protamine family of sperm nuclear proteins. Genome Biol 8:227
27. Junghans M, Kreuter J, Zimmer A (2001) Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. Biochim Biophys Acta 1544:177-188
28. Mani V, Adler E, Briley-Saebo KC et al (2008) Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 60:73-81
29. Sadek H, Latif S, Collins R, Garry MG, Garry DJ (2008) Use of ferumoxides for stem cell labeling. Regen Med 3:807-816
30. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39:56-63
31. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC (2002) Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205
32. Kosswig N, Rice S, Daugherty A, Post SR (2003) Class A scavenger receptormediated adhesion and internalization require distinct cytoplasmic domains. J Biol Chem 278:34219-34225
33. Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin- and caveolaemediated endocytosis. Biochem J 377:159-169
34. Lochmann D, Weyermann J, Georgens C, Prassl R, Zimmer A (2005) Albumin- protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization. Eur J Pharm Biopharm 59:419-429
35. Weyermann J, Lochmann D, Georgens C, Zimmer A (2005) Albumin-protamine- oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. Eur J Pharm Biopharm 59:431-438
36. Nybo M, Madsen JS (2008) Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 103:192-196
37. Levy JH, Zaidan JR, Faraj B (1986) Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes. Anesth Analg 65:739-742
38. Kharidia R, Friedman KA, Liang JF (2008) Improved gene expression using low molecular weight peptides produced from protamine sulfate. Biochemistry (Mosc) 73:1162-1168
39. Anderson SA, Glod J, Arbab AS et al (2005) Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105:420-425
40. Daldrup-Link HE, Rudelius M, Oostendorp RA et al (2005) Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol 12:502-510
41. Daldrup-Link HE, Meier R, Rudelius M et al (2005) In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/ neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 15:4-13
42. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW (2005) Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 54:769-774